Skip to main content

OpenAI

By Jessica Hagen | 11:53 am | January 21, 2026
The $50 million Horizon 1000 pilot initiative will support countries in Africa, beginning in Rwanda, as they work to apply AI technology in their healthcare systems.
By Jessica Hagen | 03:15 pm | January 07, 2026
ChatGPT Health will allow users to upload their personal medical records to allow ChatGPT to help them navigate their personal health journey and answer everyday questions.
By Nathan Eddy | 12:33 pm | January 06, 2026
A Mesothelioma Center report finds that more than half of Americans use ChatGPT for medical symptoms, widening a gap between patient reliance on AI and clinician concerns.
By Jessica Hagen | 03:54 pm | December 12, 2025
Dr. Doug Fridsma, former ONC chief science officer and current CMIO at Health Universe, discusses the challenges of AI in healthcare and balancing innovation with privacy, safety and regulation.
By Jessica Hagen | 12:11 pm | December 10, 2025
The report shows that enterprise AI adoption has surged, with healthcare among the fastest‑growing sectors at 8x year‑over‑year adoption.
By Jessica Hagen | 01:43 pm | October 03, 2025
The company said it worked with mental health and teen experts to help chatGPT recognize signs that a teen may be thinking of harming themselves.
By Jessica Hagen | 10:08 am | August 19, 2025
Lee Kim, HIMSS senior principal of cybersecurity and privacy, spoke with MobiHealthNews about GPT-5 use in healthcare. She emphasized that patient safety and cybersecurity must remain top priorities for developers.
By Jessica Hagen | 04:14 pm | August 07, 2025
The company says the model excels in healthcare applications, outperforming previous models on real-world clinical tasks and is already being adopted by healthcare companies.
By Jessica Hagen | 12:14 pm | May 15, 2025
The offering measures AI's real-world performance and safety around handling realistic medical conversations, using physician-created rubrics and GPT-4.1 scoring.
By Anthony Vecchione | 01:39 pm | February 11, 2025
OpenAI cofounder Sam Altman says the company "is not for sale."